Donald Notman - Net Worth and Insider Trading

Donald Notman Net Worth

The estimated net worth of Donald Notman is at least $1 Million dollars as of 2024-05-24. Donald Notman is the CFO of Ocular Therapeutix Inc and owns about 195,356 shares of Ocular Therapeutix Inc (OCUL) stock worth over $1 Million. Details can be seen in Donald Notman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald Notman has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).

Transaction Summary of Donald Notman

To

Donald Notman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald Notman owns 1 companies in total, including Ocular Therapeutix Inc (OCUL) .

Click here to see the complete history of Donald Notman’s form 4 insider trades.

Insider Ownership Summary of Donald Notman

Ticker Comapny Transaction Date Type of Owner
OCUL Ocular Therapeutix Inc 2024-02-05 Chief Financial Officer

Donald Notman Latest Holdings Summary

Donald Notman currently owns a total of 1 stock. Donald Notman owns 195,356 shares of Ocular Therapeutix Inc (OCUL) as of February 5, 2024, with a value of $1 Million.

Latest Holdings of Donald Notman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCUL Ocular Therapeutix Inc 2024-02-05 195,356 5.80 1,133,065

Holding Weightings of Donald Notman


Donald Notman Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald Notman has made a total of 4 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Ocular Therapeutix Inc is the sale of 6,212 shares on February 5, 2024, which brought Donald Notman around $30,190.

Insider Trading History of Donald Notman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald Notman Trading Performance

GuruFocus tracks the stock performance after each of Donald Notman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald Notman is 10.15%. GuruFocus also compares Donald Notman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald Notman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Donald Notman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Donald Notman

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.83
Relative Return to S&P 500(%) 9.26

Donald Notman Ownership Network

Ownership Network List of Donald Notman

No Data

Ownership Network Relation of Donald Notman


Donald Notman Owned Company Details

What does Ocular Therapeutix Inc do?

Who are the key executives at Ocular Therapeutix Inc?

Donald Notman is the Chief Financial Officer of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .

Ocular Therapeutix Inc (OCUL) Insider Trades Summary

Over the past 18 months, Donald Notman made 3 insider transaction in Ocular Therapeutix Inc (OCUL) with a net sale of 19,121. Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 51,149 shares made by Antony C. Mattessich , a net sale of 21,358 shares made by Rabia Gurses Ozden , and a net sale of 19,041 shares made by Philip C. Strassburger .

In summary, during the past 3 months, insiders sold 0 shares of Ocular Therapeutix Inc (OCUL) in total and bought 930,851 shares, with a net purchase of 930,851 shares. During the past 18 months, 134,055 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,341,757 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocular Therapeutix Inc Insider Transactions

No Available Data

Donald Notman Mailing Address

Above is the net worth, insider trading, and ownership report for Donald Notman. You might contact Donald Notman via mailing address: C/o Ocular Therapeutix, Inc., 15 Crosby Drive, Bedford Ma 01730.

Discussions on Donald Notman

No discussions yet.